The U.S. Food and Drug Administration (FDA) is interested in the development of resources to reduce the use of opioids where alternatives exist, so ACEP shared its extensive opioid resources. To view those resources, click here. Our two opioid-related point-of-care tools—MAP (managing acute pain) and BUPE (buprenorphine)—are now available on our new app, emPOC, available through the Apple Store and Google Play.
ACEP Shares Opioid Resources with FDA
August 11, 2022 - 0 Comment
July 7, 2022 - 0 Comment
March 21, 2022 - 0 Comment
ACEP Now: Vol 41 – No 08 – August 2022